These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12728937)

  • 21. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.
    Betriu C; Redondo M; Boloix A; Gómez M; Culebras E; Picazo JJ
    J Antimicrob Chemother; 2001 Dec; 48(6):911-3. PubMed ID: 11733478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
    Livermore DM; Warner M; Mushtaq S; North S; Woodford N
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
    Kaya O; Akcam FZ; Temel EN
    Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.
    Quiles-Melero I; García-Perea A; de Pablos M; Gómez-Gil R; Mingorance J
    Int J Med Microbiol; 2012 Jul; 302(3):145-7. PubMed ID: 22578666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
    Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
    Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistance to linezolid in Staphylococcus aureus before its release].
    Akpabie A; Naga H; Giraud K; Al Rahiss R; Nadai S
    Pathol Biol (Paris); 2004 Oct; 52(8):493-6. PubMed ID: 15465271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
    Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 32. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
    Clark C; Kosowska-Shick K; McGhee P; Dewasse B; Beachel L; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3118-21. PubMed ID: 19433566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
    Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
    Candel FJ; Morales G; Picazo JJ
    Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
    Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
    Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
    Grohs P; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.
    Gao W; Chua K; Davies JK; Newton HJ; Seemann T; Harrison PF; Holmes NE; Rhee HW; Hong JI; Hartland EL; Stinear TP; Howden BP
    PLoS Pathog; 2010 Jun; 6(6):e1000944. PubMed ID: 20548948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
    Miller K; O'Neill AJ; Wilcox MH; Ingham E; Chopra I
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1940-4. PubMed ID: 18378719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.